hotspot -WSS

hotspot

author：entertainment 2025-10-01 08:21:20 - browse：4

BARCELONA, Spain — Some of the patients waiting in the oncology ward of a hospital here, with its green-tiled floor and white walls, had arrived for a newfangled remedy for blood cancers, what’s known as a CAR-T therapy.

The patients were not here for one of the brand-name medicines — a Kymriah or Yescarta — that have shown the power of these cell-based approaches and helped reap their makers hundreds of millions of dollars. Rather, they would be receiving a CAR-T brewed up right here at Hospital Clínic de Barcelona.

Under a special European policy, the CAR-T developed by the hospital’s experts had won regulatory approval in Spain and was reimbursed by the national health system like other authorized medications. The therapy provided another option for patients, all at a price of 89,000 euros ($97,000), roughly a third of the list prices of the CAR-T products from biopharma companies.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： How to fix the rural physician shortage in the U.S.

Wikipedia

WSS

Can medical device makers keep up in the race to treat obesity?

Altering the blood type of lungs raises potential for universal organs for transplants

Readout LOUD podcast: Biotech layoffs, stock slump, 2024 preview

Bispecific antibodies are next new thing in cancer immunotherapy

The thinking behind the controversial eating disorder chatbot Tessa

Parkinson’s finding may lead to tests and, someday, treatments

explore

hotspot

leisure time

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Correcting Robert F. Kennedy Jr.'s vaccine 'facts'

Walensky prepares to leave CDC — and Congress — behind

Science's Marcia McNutt, trailblazer for women, encounters sexism scandal

DIEP, the 'gold standard' of breast reconstruction, is under threat

Millions may soon lose Medicaid when they don't have to

At least 13 dead in Texas as scorching temps continue

Science's Marcia McNutt, trailblazer for women, encounters sexism scandal

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Bispecific antibodies are next new thing in cancer immunotherapy

hotspot

What to make of Gilead’s Trodelvy troubles and Elevation Oncology’s rise

FDA approves first new drug developed for postpartum depression

EU regulator recommends expanding Mounjaro approval to obesity

How to fix the rural physician shortage in the U.S.

Eli Lilly’s Mounjaro succeeds in second weight

Canadian wildfire dangers should prompt more proactive mitigation from government: Experts

Wikipedia

focus

Wikipedia

focus